New study aims to improve agitation measurement in mental health
NCT ID NCT07116694
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 2 times
Summary
This study looked at how well patients, their family members, and doctors agree when rating agitation episodes in people with bipolar disorder or schizophrenia. Thirty-three adults received a treatment called BXCL501, and researchers compared different questionnaires to see which ones work best. The goal was to find simpler, more reliable ways to measure agitation in future studies and clinics.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR I DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
BioXcel Clinical Research Site 101
St Louis, Missouri, 63125, United States
-
BioXcel Clinical Research Site 102
Orange, California, 92868, United States
-
BioXcel Clinical Research Site 103
Chino, California, 91710, United States
-
BioXcel Clinical Research Site 105
Oceanside, California, 92056, United States
-
BioXcel Clinical Research Site 106
Las Vegas, Nevada, 89119, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a phone app teach the brain to read social cues?
- Can a gentle brain current silence voices that medication Can't?